Cannabidiol
- Generic Name
- Cannabidiol
- Brand Names
- Epidiolex, Sativex, Epidyolex
- Drug Type
- Small Molecule
- Chemical Formula
- C21H30O2
- CAS Number
- 13956-29-1
- Unique Ingredient Identifier
- 19GBJ60SN5
- Background
Cannabidiol, or CBD, is one of at least 85 active cannabinoids identified within the Cannabis plant. It is a major phytocannabinoid, accounting for up to 40% of the Cannabis plant's extract, that binds to a wide variety of physiological targets of the endocannabinoid system within the body. Although the exact medical implications are currently being investig...
- Indication
When used in combination with delta-9-tetrahydrocannabinol as the product Sativex, cannabidiol was given a standard marketing authorization (ie. a Notice of Compliance (NOC)) by Health Canada for the following indications:
...
- Associated Conditions
- Multiple Sclerosis, Seizures, Severe Pain, Moderate Pain
- Associated Therapies
- -
Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy
- Conditions
- Interventions
- First Posted Date
- 2023-11-02
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 50
- Registration Number
- NCT06113237
- Locations
- 🇺🇸
United Biosource LLC, Morgantown, West Virginia, United States
Topical Cannabidiol for Treating Carpal Tunnel Syndrome
- First Posted Date
- 2023-10-31
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 20
- Registration Number
- NCT06108349
Cannabidiol Medication Intervention Trial
- First Posted Date
- 2023-08-28
- Last Posted Date
- 2024-03-27
- Lead Sponsor
- Sunnybrook Health Sciences Centre
- Target Recruit Count
- 40
- Registration Number
- NCT06014424
- Locations
- 🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
🇨🇦Ontario Shores Centre for Mental Health Sciences, Whitby, Ontario, Canada
🇨🇦University of Calgary, Calgary, Alberta, Canada
Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis
- Conditions
- Interventions
- First Posted Date
- 2023-07-12
- Last Posted Date
- 2023-11-27
- Lead Sponsor
- Incannex Healthcare Ltd
- Target Recruit Count
- 128
- Registration Number
- NCT05942911
- Locations
- 🇦🇺
Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
🇦🇺Emeritus Research, Sydney, New South Wales, Australia
🇦🇺Captain Sterling Medical Centre, Nedlands, Western Australia, Australia
Cannabidiol for Bipolar Depression (CBD-BD)
- First Posted Date
- 2023-05-22
- Last Posted Date
- 2024-01-10
- Lead Sponsor
- University of British Columbia
- Target Recruit Count
- 360
- Registration Number
- NCT05867849
- Locations
- 🇨🇦
Providence Care Hospital, Kingston, Ontario, Canada
🇨🇦St. Joseph's Healthcare, Hamilton, Ontario, Canada
🇨🇦Dalhousie University, Halifax, Nova Scotia, Canada
Evaluating Efficacy and Safety of CBD TPM Capsules for Use in Insomnia
- First Posted Date
- 2023-05-03
- Last Posted Date
- 2023-05-03
- Lead Sponsor
- Avecho Biotechnology
- Target Recruit Count
- 540
- Registration Number
- NCT05840822
Cannabidiol to Reduce Anxiety Reactivity
- Conditions
- Interventions
- First Posted Date
- 2023-04-21
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 63
- Registration Number
- NCT05823753
- Locations
- 🇺🇸
University of California, San Deigo, San Diego, California, United States
CBD for Individuals at Risk for Alzheimer's Disease
- First Posted Date
- 2023-04-20
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 236
- Registration Number
- NCT05822362
- Locations
- 🇺🇸
University of Colorado - Anschutz Medical Campus, Aurora, Colorado, United States
Long-Term Follow-Up of a Cohort of Participants Prescribed Epidyolex in France in a Real-life Setting
- First Posted Date
- 2023-03-16
- Last Posted Date
- 2024-08-16
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 158
- Registration Number
- NCT05772429
- Locations
- 🇫🇷
GH Est - Hôpital Femme Mère Enfant, Bron, France
🇫🇷CHU Bordeaux - service adulte, Bordeaux, France
🇫🇷CHU Grenoble - service adulte, Grenoble, France
The Effects of CBD Isolate on Menstrual-Related Symptoms
- First Posted Date
- 2023-01-11
- Last Posted Date
- 2023-01-11
- Lead Sponsor
- Canopy Growth Corporation
- Target Recruit Count
- 33
- Registration Number
- NCT05679830
- Locations
- 🇺🇸
James Madison University, Harrisonburg, Virginia, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.